This test is most useful if any of these apply to you.
If you have stubborn asthma, year-round sneezing, or eczema that flares without an obvious trigger, an outdoor mold may be part of the picture. Cladosporium herbarum is one of the most abundant fungi in outdoor air worldwide, and your immune system can quietly build up antibodies against it long before you connect the dots.
This test measures the level of those antibodies in your blood. It tells you whether your body is treating this mold as a threat, which is useful information when standard allergy panels skip mold or when your symptoms do not match the usual suspects like pollen, dust mites, or pets.
The lab measures Cladosporium herbarum specific IgE (immunoglobulin E), an antibody your B cells produce when your immune system identifies this mold as an allergen. Once made, these antibodies bind to mast cells and basophils, immune cells that release histamine and other chemicals when you breathe in the mold again. That release drives the runny nose, wheeze, itch, or rash that follows exposure.
A positive result means your immune system is sensitized to Cladosporium herbarum. Sensitization is not the same as a clinical allergy. Some people have measurable antibodies without symptoms, and a few people have mold-driven symptoms without measurable blood antibodies, because the antibodies are produced locally in the nasal lining instead. This is why the result is most useful when read alongside your symptom history.
In children, sensitization to Cladosporium herbarum tends to show up alongside more troublesome asthma. A school-aged study in damp buildings found that elevated mold IgE was strongly clustered in boys with asthma or wheeze, and most of the children with Cladosporium herbarum antibodies had active respiratory disease. In a pediatric allergy clinic, Cladosporium herbarum produced the highest frequency of positive fungal antibody tests, and positives tracked with more severe asthma and eczema.
In severe asthma that does not respond well to inhalers, a recognized subgroup called severe asthma with fungal sensitization (SAFS) is defined by severe asthma plus fungal sensitization in the absence of allergic bronchopulmonary aspergillosis, with Aspergillus fumigatus, Alternaria, and Cladosporium among the fungi most commonly implicated. A recent meta-analysis found that Cladosporium sensitization was significantly associated with severe asthma (odds ratio 2.63). Pediatric severe asthma with fungal sensitization has been linked to very high total IgE levels, earlier symptom onset, more oral steroid use, and an inflammatory pathway involving IL-33 (an immune signaling protein) that resists standard steroid treatment. Knowing whether you carry mold antibodies can help explain why a difficult-to-control asthma case behaves the way it does.
For year-round nasal symptoms, this test fills a gap that pollen-focused panels often miss. In studies of patients labeled as having non-allergic rhinitis because their standard blood and skin tests were negative, a subset had positive nasal challenges to mold extracts including Alternaria and Cladosporium. This points to local allergic rhinitis, where the antibodies are made in the nasal lining rather than circulating in the bloodstream. Mold-specific local reactivity is uncommon overall, but when present it can explain symptoms that otherwise look unexplained.
In chronic sinusitis populations, mold sensitization including Cladosporium herbarum is detectable but uncommon. A positive result in someone with persistent congestion can redirect treatment toward exposure reduction and targeted allergy care rather than another round of antibiotics.
In adults with atopic dermatitis (eczema), antibodies to Cladosporium herbarum allergen components, including the well-characterized major allergen Cla h 8 (a mannitol dehydrogenase enzyme recognized by roughly 57% of Cladosporium-allergic patients), are more common in people with more severe skin disease, and they appear more often in people who also have asthma. The link is not a cause-and-effect story for every patient, but it offers a clue when your eczema is severe, hard to control, or paired with breathing symptoms.
A single antibody reading is a snapshot. In children, both total IgE and mold-specific IgE rise with age and tend to peak around puberty, so a borderline result at one age may look different a year later. Sensitization patterns also shift over time, especially in young people and in anyone changing homes, jobs, or climates.
Tracking your number across years is more informative than a one-time check. No major allergy guideline specifies a retesting interval for mold-specific IgE, so this is a matter of clinical judgment. A reasonable rhythm some clinicians use: get a baseline now, repeat in 6 to 12 months if you are starting allergen avoidance, mold remediation at home, or immunotherapy, then at least annually if your symptoms continue. A rising trend alongside worsening symptoms is a stronger signal than any single value.
A normal or negative result does not rule out mold-driven disease. Some people with clear nasal symptoms after mold exposure have negative blood and skin tests but positive nasal challenges, because their antibodies are produced locally in the nasal lining and never spill into the bloodstream in measurable amounts.
A positive result without symptoms is common and does not automatically require treatment. It does warrant a careful look at your home and workplace for visible mold, water damage, and dampness, and a low threshold for testing other aeroallergens to see the full picture of your sensitization. Pair this test with total IgE and a broader inhalant panel (dust mite, pet dander, pollens, other molds) to understand whether mold is your dominant trigger or one of many.
If you have asthma that is difficult to control, eczema that keeps flaring, or rhinitis that does not respond to standard therapy, a positive Cladosporium herbarum result is a reason to involve an allergist. They can confirm with skin testing or a nasal challenge, evaluate you for severe asthma with fungal sensitization, and discuss whether allergen-specific immunotherapy is appropriate. A small randomized trial (30 children) of immunotherapy with a purified Cladosporium herbarum preparation reduced medication use and bronchial and eye sensitivity over 10 months, but systemic reactions were very common (13 of 16 children in the active group), and reviews rate the overall evidence for mold immunotherapy as low quality, with stronger data for Alternaria than for Cladosporium. Changes in blood antibody levels did not closely track clinical improvement.
Evidence-backed interventions that affect your Cladosporium Herbarum Mold IgE level
Cladosporium Herbarum Mold IgE is best interpreted alongside these tests.
Cladosporium Herbarum Mold IgE is included in these pre-built panels.